STRATA Skin Sciences Eyes Market Growth

STRATA Skin Sciences(NASDAQ:SSKN) reported its second-quarter 2025 results on August 13, 2025, highlighting significant developments in reimbursement expansion, ongoing litigation, and commercial initiatives that are expected to shape the company’s long-term outlook despite international headwinds.The American Medical Association (AMA) revised the Current Procedural Terminology (CPT) codes in May 2025, enabling reimbursement for XTRAC excimer laser treatments across 30 dermatologic indications beyond psoriasis. The effective date is targeted for January 1, 2027, with the possibility of acceleration into 2026 through temporary G codes. This change could triple the company’s total available market to 30 million patients.This expansion positions STRATA Skin Sciences to capture a significantly larger patient population, potentially accelerating revenue growth if temporary G codes are approved for earlier implementation.Continue readingWeiter zum vollständigen Artikel bei MotleyFool Weiter zum vollständigen Artikel bei MotleyFool